Understanding this is useful because it means most of the early side effects have practical solutions
Disclosures: Seema Alam: Nothing to Disclose, Bikrant Biharilal Raghuvanshi: Nothing to Disclose, Tamoghna Biswas: Nothing to Disclose, Vikrant Sood: Nothing to Disclose, Rajeev Khanna: Nothing to Disclose, Snigdha Verma: Nothing to Disclose 2113 IMPROVED OUTCOMES OF ACUTE LIVER FAILURE WITH EXTRACORPOREAL LIVER SUPPORT- A MORE THAN A DECADE OF EXPERIENCE FROM A TERTIARY CENTRE Rakhi Maiwall 1 Meenu Bajpai 2 Harsh Vardhan Tevethia 2 Samba Siva Rao Pasupuleti 3 Fagun Sharma 2 Bindiya Arora 2 Sumegh Talwalkar 2 Mohit kumar Prajapati 2 Prashant Agarwal 2 Rajendra Prasad Mathur 2 Chandani Bhagat 2 Sherin Thomas 2 Shiv Kumar Sarin 2 , 1 Institute of Liver and Biliary Sciences, 2 Institute of Liver & Biliary Sciences, 3 Mizoram University, Pachhunga University College Campus Background: There is a reduction in the deaths of acute liver failure (ALF) patients, with use of extracorporeal liver support systems (ECLS), therapeutic plasma-exchange (TPE) and continuous renal replacement therapy (CRRT)
But air bubbles are a dosing accuracy issue
Reflux can happen to anyone, occurring when the lid to the esophagus is left open
adults aged 20 and over, theres a 41.9% prevalence of obesity according to the Centers for Disease Control and Prevention
